Journal of the American Society of Hypertension
Volume 2, Issue 2 , Pages 97-105, March 2008

Hypertension prevention and control in Canada

  • Norman R.C. Campbell, MD

      Affiliations

    • Corresponding Author InformationCorresponding author: Norman R. C. Campbell, MD, Libin Cardiovascular Institute of Alberta, Health Sciences Centre, University of Calgary, 3330 Hospital Drive NW, Calgary, Alberta, T2N 4N1 Canada.

Departments of Medicine, Community Health Sciences, and Pharmacology and Therapeutics University of Calgary, Libin Cardiovascular Institute of Alberta, Alberta, Canada

Received 23 July 2007; accepted 4 October 2007.

Abstract 

Canada has a similar prevalence of hypertension to the U.S., which is lower than the prevalence in many European countries. In contrast, Canada had similar treatment and control rates of hypertension to Europe, which are substantially lower than those of the U.S. To address this disparity, a national strategic plan was developed. While the strategy never received government resources for implementation, the Canadian hypertension community has successfully initiated certain aspects of the strategy. To date, programs include: a health professional education program, a national surveillance program, a public awareness program, and a program to reduce dietary sodium. The initiatives rely heavily on volunteers and on collaboration between many organizations and various government departments. Initially largely supported by corporate donations, the programs have received increased government resources over the last 2 years. The development of a funded leadership position beginning in 2006 (Canadian Institutes of Health Research Canada Chair in Hypertension Prevention and Control) has accelerated the initiatives. In the first 4 years of the health professional education program, there were large increases in the diagnosis and treatment of hypertension with corresponding reductions in cardiovascular disease. The Canadian programs could be adopted by countries with an organized and committed hypertension community.

Keywords: High blood pressure, knowledge translation, education, epidemiology

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Dr. Norman Campbell acknowledges the Canadian Institutes of Health Research for their support of the Canada Chair in Hypertension Prevention and Control. Dr. Campbell has provided talks for and sits on Advisory Boards of most pharmaceutical companies that produce antihypertensive drugs in Canada.

PII: S1933-1711(07)00203-3

doi:10.1016/j.jash.2007.10.001

Journal of the American Society of Hypertension
Volume 2, Issue 2 , Pages 97-105, March 2008